Published in

Wiley, British Journal of Haematology, 5(192), p. 853-868, 2020

DOI: 10.1111/bjh.16945

Links

Tools

Export citation

Search in Google Scholar

Optimising the value of immunomodulatory drugs during induction and maintenance in transplant ineligible patients with newly diagnosed multiple myeloma: results from Myeloma XI, a multicentre, open-label, randomised, Phase III trial.

Journal article published in 2020 by Graham H. Jackson, Jackson Gh, Charlotte Pawlyn, David A. Cairns, Cairns Da, Alina Striha, Corinne Collett, Anna Waterhouse, John R. Jones, Jamie Wilson, Jones Jr, Craig Taylor, Bhuvan Kishore, Cathy D. Williams, Mamta Garg and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO